Dihydrotanshinone I

TargetMol
Product Code: TAR-T3374
Supplier: TargetMol
CodeSizePrice
TAR-T3374-5mg5mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3374-10mg10mg£144.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3374-25mg25mg£224.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3374-50mg50mg£293.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3374-100mg100mg£438.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3374-500mg500mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Dihydrotanshinone I is a natural compound extracted from Salvia miltiorrhiza Bunge used for treating of cardiovascular diseases.
CAS:
87205-99-0
Formula:
C18H14O3
Molecular Weight:
278.307
Pathway:
Microbiology/Virology; Immunology/Inflammation
Purity:
0.9937
SMILES:
C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c(C)cccc12
Target:
SARS-CoV; ROS

References

Wang L, et al. Dihydrotanshinone I induced apoptosis and autophagy through caspase dependent pathway in colon cancer. Phytomedicine. 2015 Nov 15;22(12):1079-87. Wei, Y., Xu, M., Ren, Y., Lu, G., Xu, Y., Song, Y., & Ji, H. (2016). The cardioprotection of dihydrotanshinone I against myocardial ischemia?reperfusion injury via inhibition of arachidonic acid ?-hydroxylase.?Canadian Journal Of Physiology And Pharmacology,?94(12), 1267-1275. doi: 10.1139/cjpp-2016-0036 Wei Z, Zhan X, Ding K, et al. Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo. Frontiers in Pharmacology. 2021: 2623. Li X W, Yuan S C, Wang M, et al.Rosmarinic acid ameliorates autoimmune responses through suppression of intracellular nucleic acid-mediated type I interferon expression.Biochemical and Biophysical Research Communications.2023